Consequence of Cerebral Embolism after Transcatheter Aortic Valve Implantation Compared with Contemporary Surgical Aortic Valve Replacement: Effect on Health-Related Quality of Life

Circulation: Cardiovascular Interventions

Volumn 8, Issue 3, 2015, Pages

  Uddin, Akhlaque ^a   Fairbairn, Timothy A ^a   Djoukhader, Ibrahim K ^b   Igra, Mark ^b   Kidambi, Ananth ^a   Motwani, Manish ^a   Herzog, Bernhard ^a   Ripley, David P ^a   Musa, Tarique Al ^a   Goddard, Anthony J P ^b   Blackman, Daniel J ^b   Plein, Sven ^a,b   Greenwood, John P ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

aortic valve stenosis; magnetic resonance imaging; quality of life; transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN EMBOLISM; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIFFUSION WEIGHTED IMAGING; EUROSCORE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; SURGICAL AORTIC VALVE REPLACEMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; CLINICAL TRIAL; HEART VALVE REPLACEMENT; INTRACRANIAL EMBOLISM; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRACRANIAL EMBOLISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84937579228     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.114.001913     Document Type: Article

References (25)

1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL and Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-2496.
2. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695. doi: 10.1056/NEJMoa1200384.
3. Fairbairn TA, Meads DM, Mather AN, Motwani M, Pavitt S, Plein S, Blackman DJ, Greenwood JP. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J Am Coll Cardiol. 2012;59:1672-1680. doi: 10.1016/j. jacc.2012.01.035.
4. Fairbairn TA, Meads DM, Hulme C, Mather AN, Plein S, Blackman DJ, Greenwood JP. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart. 2013;99:914-920. doi: 10.1136/heartjnl-2013-303722.
5. Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M, Johansson U, Wendt D, Jakob HG, Forsting M, Sack S, Erbel R, Eggebrecht H. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121:870-878. doi: 10.1161/ CIRCULATIONAHA.109.855866.
6. Kahlert P, Al-Rashid F, Döttger P, Mori K, Plicht B, Wendt D, Bergmann L, Kottenberg E, Schlamann M, Mummel P, Holle D, Thielmann M, Jakob HG, Konorza T, Heusch G, Erbel R, Eggebrecht H. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation. 2012;126:1245-1255. doi: 10.1161/ CIRCULATIONAHA.112.092544.
7. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, Schild HH, Schwab JO, Mellert F, Fimmers R, Nickenig G, Thomas D. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55:1427-1432. doi: 10.1016/j. jacc.2009.12.026.
8. Rodés-Cabau J, Dumont E, Boone RH, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, De Larochellière R, Jayasuria C, Villeneuve J, Marrero A, Côté M, Pibarot P, Webb JG. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011;57:18-28. doi: 10.1016/j. jacc.2010.07.036.
9. Stolz E, Gerriets T, Kluge A, Klövekorn WP, Kaps M, Bachmann G. Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement: implications for future neuroprotective trials? Stroke. 2004;35:888-892. doi: 10.1161/01. STR.0000120306.82787.5A.
10. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-1454. doi: 10.1016/j.jacc.2012.09.001.
11. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
12. Barbut D, Lo YW, Hartman GS, Yao FS, Trifiletti RR, Hager DN, Hinton RB, Gold JP, Isom OW. Aortic atheroma is related to outcome but not numbers of emboli during coronary bypass. Ann Thorac Surg. 1997;64:454-459. doi: 10.1016/S0003-4975(97)00523-7.
13. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343:611-617. doi: 10.1056/ NEJM200008313430903.
14. Ware JE Jr, Kosinski M, Turner-Bowker DM, Gandek B. User's Manual for the SF-12v2 Health Survey. Lincoln, RI: Quality Metric Incoporated; 2002.
15. Nietlispach F, Wijesinghe N, Gurvitch R, Tay E, Carpenter JP, Burns C, Wood DA, Webb JG. An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv. 2010;3:1133-1138. doi: 10.1016/j.jcin.2010.05.022.
16. Fairbairn TA, Mather AN, Bijsterveld P, Worthy G, Currie S, Goddard AJ, Blackman DJ, Plein S, Greenwood JP. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012;98:18-23. doi: 10.1136/heartjnl-2011-300065.
17. Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, Amat-Santos IJ, Cheung A, Ye J, Binder RK, van der Boon RM, Van Mieghem N, Benitez LM, Pérez S, Lopez J, San Roman JA, Doyle D, Delarochellière R, Urena M, Leipsic J, Dumont E, Rodés- Cabau J. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041-3053. doi: 10.1161/ CIRCULATIONAHA.112.110981.
18. Pugsley W, Klinger L, Paschalis C, Treasure T, Harrison M, Newman S. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994;25:1393-1399.
19. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. doi: 10.1056/ NEJMoa1103510.
20. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695. doi: 10.1056/NEJMoa1200384.
21. Blum S, Luchsinger JA, Manly JJ, Schupf N, Stern Y, Brown TR, DeCarli C, Small SA, Mayeux R, Brickman AM. Memory after silent stroke: hippocampus and infarcts both matter. Neurology. 2012;78:38-46. doi: 10.1212/WNL.0b013e31823ed0cc.
22. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011;42:722-727. doi: 10.1161/STROKEAHA.110.595082.
23. Ussia GP, Mulè M, Barbanti M, Cammalleri V, Scarabelli M, Immè S, Capodanno D, Ciriminna S, Tamburino C. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J. 2009;30:1790-1796. doi: 10.1093/eurheartj/ehp171.
24. Zamvar V, Williams D, Hall J, Payne N, Cann C, Young K, Karthikeyan S, Dunne J. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: prospective randomised controlled trial. BMJ. 2002;325:1268.
25. Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2013;62:531-539. doi: 10.1016/j. jacc.2013.03.073.